Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lung Cancer Symptom Scale outcomes in relation to standard efficacy measures: an analysis of the phase III study of pemetrexed versus docetaxel in advanced non-small cell lung cancer.
de Marinis F, Pereira JR, Fossella F, Perry MC, Reck M, Salzberg M, Jassem J, Peterson P, Liepa AM, Moore P, Gralla RJ. de Marinis F, et al. Among authors: perry mc. J Thorac Oncol. 2008 Jan;3(1):30-6. doi: 10.1097/JTO.0b013e31815e8b48. J Thorac Oncol. 2008. PMID: 18166838 Free article.
Treatment of elderly non-small cell lung cancer patients with three different schedules of weekly paclitaxel in combination with carboplatin: subanalysis of a randomized trial.
Ramalingam S, Barstis J, Perry MC, La Rocca RV, Nattam SR, Rinaldi D, Clark R, Mills GM, Belani CP. Ramalingam S, et al. Among authors: perry mc. J Thorac Oncol. 2006 Mar;1(3):240-4. doi: 10.1016/s1556-0864(15)31574-4. J Thorac Oncol. 2006. PMID: 17409863 Free article. Clinical Trial.
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
Stinchcombe TE, Hodgson L, Herndon JE 2nd, Kelley MJ, Cicchetti MG, Ramnath N, Niell HB, Atkins JN, Akerley W, Green MR, Vokes EE; Cancer and Leukemia Group B. Stinchcombe TE, et al. J Thorac Oncol. 2009 Sep;4(9):1117-25. doi: 10.1097/JTO.0b013e3181b27b33. J Thorac Oncol. 2009. PMID: 19652624 Free PMC article.
Sex differences in outcome with bevacizumab therapy: analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group Trial 4599.
Brahmer JR, Dahlberg SE, Gray RJ, Schiller JH, Perry MC, Sandler A, Johnson DH. Brahmer JR, et al. Among authors: perry mc. J Thorac Oncol. 2011 Jan;6(1):103-8. doi: 10.1097/JTO.0b013e3181fa8efd. J Thorac Oncol. 2011. PMID: 21079521 Free PMC article. Clinical Trial.
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy.
Crawford J, Robert F, Perry MC, Belani C, Williams D; Anemia Prevention in NSCLC Group. Crawford J, et al. Among authors: perry mc. J Thorac Oncol. 2007 Mar;2(3):210-20. doi: 10.1097/JTO.0b013e318031cd9a. J Thorac Oncol. 2007. PMID: 17410044 Free article. Clinical Trial.
Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
Belani CP, Ramalingam S, Perry MC, LaRocca RV, Rinaldi D, Gable PS, Tester WJ. Belani CP, et al. Among authors: perry mc. J Clin Oncol. 2008 Jan 20;26(3):468-73. doi: 10.1200/JCO.2007.13.1912. J Clin Oncol. 2008. PMID: 18202422 Clinical Trial.
History of small-cell lung cancer.
Haddadin S, Perry MC. Haddadin S, et al. Among authors: perry mc. Clin Lung Cancer. 2011 Mar;12(2):87-93. doi: 10.1016/j.cllc.2011.03.002. Epub 2011 Apr 8. Clin Lung Cancer. 2011. PMID: 21550554 Review.
253 results